Nanoform Finland Oyj (NANOFH.HE)

EUR 1.29

(2.7%)

Operating Expenses Summary of Nanoform Finland Oyj

Nanoform Finland Oyj's latest annual operating expenses in 2023 was 6.58 Million EUR , down -73.17% from previous year.
Nanoform Finland Oyj's latest quarterly operating expenses in 2024 Q1 was 7 Million EUR , up 325.75% from previous quarter.
Nanoform Finland Oyj reported a annual operating expenses of 24.55 Million EUR in annual operating expenses 2022, up 14.23% from previous year.
Nanoform Finland Oyj reported a annual operating expenses of 21.49 Million EUR in annual operating expenses 2021, up 8.06% from previous year.
Nanoform Finland Oyj reported a quarterly operating expenses of 1.88 Million EUR for 2024 Q2, down -3.51% from previous quarter.
Nanoform Finland Oyj reported a quarterly operating expenses of 5.44 Million EUR for 2023 Q3, down -17.52% from previous quarter.

Annual Operating Expenses Chart of Nanoform Finland Oyj (2023 - 2017)

Historical Annual Operating Expenses of Nanoform Finland Oyj (2023 - 2017)

Year	Operating Expenses	Operating Expenses Growth
2023	6.58 Million EUR	-73.17%
2022	24.55 Million EUR	14.23%
2021	21.49 Million EUR	8.06%
2020	19.89 Million EUR	192.98%
2019	6.78 Million EUR	229.55%
2018	2.06 Million EUR	427.3%
2017	390.73 Thousand EUR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	7 Million EUR	325.75%
2024 Q2	1.88 Million EUR	-3.51%
2023 Q3	5.44 Million EUR	-17.52%
2023 Q1	5.73 Million EUR	-8.2%
2023 Q4	1.64 Million EUR	-69.76%
2023 FY	6.58 Million EUR	-73.17%
2023 Q2	6.59 Million EUR	15.13%
2022 Q3	5.61 Million EUR	-18.53%
2022 FY	24.55 Million EUR	14.23%
2022 Q4	6.24 Million EUR	11.24%
2022 Q2	6.89 Million EUR	18.57%
2022 Q1	5.81 Million EUR	-3.27%
2021 Q1	4.6 Million EUR	-3.36%
2021 Q3	5.52 Million EUR	3.13%
2021 Q4	6 Million EUR	8.69%
2021 Q2	5.35 Million EUR	16.4%
2021 FY	21.49 Million EUR	8.06%
2020 FY	19.89 Million EUR	192.98%
2020 Q4	4.76 Million EUR	21.94%
2020 Q3	3.9 Million EUR	-42.27%
2020 Q2	6.76 Million EUR	51.92%
2020 Q1	4.45 Million EUR	81.92%
2019 Q1	928 Thousand EUR	0.0%
2019 Q4	2.44 Million EUR	23.62%
2019 FY	6.78 Million EUR	229.55%
2019 Q3	1.98 Million EUR	38.24%
2019 Q2	1.43 Million EUR	54.42%
2018 FY	2.06 Million EUR	427.3%
2017 FY	390.73 Thousand EUR	0.0%

Peer Operating Expenses Comparison of Nanoform Finland Oyj

Name	Operating Expenses	Operating Expenses Difference
Biohit Oyj	6.63 Million EUR	0.752%
Herantis Pharma Oyj	-154.36 Thousand EUR	4368.4%